Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMMF is the United Kingdom's only charity dedicated specifically to cholangiocarcinoma, also known as bile duct cancer. Founded in 2002, the organization focuses on raising awareness of this rare and aggressive malignancy, providing vital information and support to patients and their families. AMMF is a significant funder of specialized research, targeting improvements in diagnostic techniques and the identification of new therapeutic pathways. The charity collaborates extensively with clinical experts, healthcare professionals, and pharmaceutical companies to advocate for better treatment access and to facilitate clinical trial participation. Through its annual conferences and global partnerships, AMMF plays a central role in the international cholangiocarcinoma research and advocacy community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMMF.